Evidence map›Paper›PMID 42506105›Full record

ReviewJournal of personalized medicine2026

The Immune System and the Plural Autisms: A Narrative Review.

Paul Whiteley, Kevin Carr, Paul Shattock, Malcolm Hooper, Carol Stott, Karl Hardy, Ben Marlow, Chandoshi Rhea Mukherjee, Athena Whiteley

Abstract readReview
In one paragraph

Review in Journal of personalized medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Paul WhiteleyESPA (Education & Services for People with Autism) Research, North House, Ferryboat Lane, Castletown, Sunderland SR5 3RL, UK.ORCID 0009-0006-1779-6588
Kevin CarrESPA (Education & Services for People with Autism) Research, North House, Ferryboat Lane, Castletown, Sunderland SR5 3RL, UK.
Paul ShattockESPA (Education and Services for People with Autism), North House, Ferryboat Lane, Sunderland SR5 3RL, UK.
Malcolm HooperESPA (Education & Services for People with Autism) Research, North House, Ferryboat Lane, Castletown, Sunderland SR5 3RL, UK.
Carol StottESPA (Education & Services for People with Autism) Research, North House, Ferryboat Lane, Castletown, Sunderland SR5 3RL, UK.
Karl HardyESPA (Education and Services for People with Autism), North House, Ferryboat Lane, Sunderland SR5 3RL, UK.
Ben MarlowSynapse Centre for Neurodevelopment, Colchester Hospital, East Suffolk and North Essex NHS Foundation Trust, Colchester CO4 5JL, UK.ORCID 0009-0008-9802-5754
Chandoshi Rhea MukherjeeWorcestershire Acute Hospitals NHS Trust, Worcester WR5 1DD, UK.
Athena WhiteleyIndependent Researcher, Sunderland SR5 3RL, UK.

Funding

The Bia-Echo Foundation None
6 · The paper itself

Abstract

Plural autisms offer one important way of organising the massive heterogeneity that is currently included under the singular diagnostic label of autism spectrum disorder (ASD). Characterised exclusively by behavioural criteria related to social communication skills and restricted or repetitive patterns of symptoms, the observable diversity in presentations and developmental trajectories partially explains the lack of universally applicable biomarkers and answers about underlying biology. One particularly important area potentially pertinent to several manifestations of the plural autisms is a connection to the immune system, whether noted across differing patterns of immune functions or following immune challenge in the context of inflammatory processes exerting an effect on developmental processes and behaviour. Utilising a narrative review, we highlight various research analysing a role for immune functions in the context of the heterogeneous autisms stretching across under-, over- and autoimmune processes. Current evidence for immune system involvement in various autisms carries considerable limitations, and studies are often based on small sample sizes, focusing on selective clinical subgroups, and using case-based observations. Notwithstanding the available evidence, substantial and more detailed further studies are required in relation to immune-related screening, building also on the currently limited evidence on the potential usefulness of personalised immune-affecting interventions following appropriate screening and identification of pertinent immune-related issues.

Indexed as

autism spectrum disorder (ASD)comorbidityimmune systeminterventionscreening

Identifiers

PMID42506105
PMCPMC13412297

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.